SCHEMBL9753340

SCHEMBL9753340

CCOC(=O)c1c(C(C)C)nn2c(Cl)ccc2c1-c1ccc(F)cc1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GCGR P47871 1/20 0.43
MAPT P10636 5/20 0.43
ALDH1A1 P00352 6/20 0.41
KDM4E B2RXH2 4/20 0.41
MEN1 O00255 3/20 0.41
KMT2A Q03164 3/20 0.41
HPGD P15428 3/20 0.41
GAA P10253 2/20 0.41
SLC10A2 Q12908 1/20 0.39
GPR55 Q9Y2T6 1/20 0.39
PKM P14618 1/20 0.39
GRM6 O15303 1/20 0.39
PRKCZ Q05513 1/20 0.39
L3MBTL1 Q9Y468 1/20 0.39
GABRA2 P47869 1/20 0.39
GABRB2 P47870 1/20 0.39
TP53 P04637 2/20 0.38
HSD17B10 Q99714 2/20 0.38
ALOX15 P16050 1/20 0.38
THRB P10828 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3820745 0.89 MAPT (0.47) GCGRMAPTALDH1A1KDM4EMEN1
SCHEMBL5089841 0.88 GCGR (0.43) GCGRMAPTALDH1A1KDM4EMEN1
SCHEMBL3822819 0.88 GCGR (0.43) GCGRMAPTALDH1A1KDM4EMEN1
SCHEMBL5095559 0.87 GCGR (0.43) GCGRMAPTALDH1A1KDM4EMEN1
SCHEMBL5094505 0.87 GCGR (0.47) GCGRMAPTALDH1A1KDM4EMEN1
SCHEMBL5101420 0.86 SLC10A2 (0.44) MAPTALDH1A1KDM4EMEN1KMT2A
SCHEMBL5101498 0.86 ALDH1A1 (0.44) GCGRMAPTALDH1A1KDM4EMEN1
SCHEMBL3819543 0.86 GCGR (0.42) GCGRMAPTALDH1A1KDM4EMEN1
SCHEMBL5095533 0.86 GCGR (0.42) GCGRMAPTALDH1A1KDM4EMEN1
SCHEMBL5093104 0.86 MAPT (0.44) GCGRMAPTALDH1A1KDM4EMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-1991018903-A1 PYRROLOPYRIDAZINE COMPOUNDS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1991-12-12 WO disclosed